SigniGene

Health & Fitness

Free · Designed for iPad. Not verified for macOS.

Now with in-app messaging and reference documentation for better support and educational information. Your DNA contains the basic building blocks for who you are, how you look and how you interact with the world. Damage or mutations to the dan can contribute to disease development and affect how you react to chemicals and therefore the medicinals you take. Pharmacogenomics is the science that uses your DNA to tell you which medicinals are good and bad for you. SigniGene brings the benefits of pharmacogenomics to everyone by making it easy to interpret the results of a genetic test into practical guidelines for dosing hundreds of common medicinals and drugs.

  • This app has not received enough ratings or reviews to display an overview.

The developer, Inviso Ltd, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info
    • User Content
    • Identifiers
    • Usage Data
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Health & Fitness
    • User Content
    • Sensitive Info
    • Diagnostics

Privacy practices may vary based, for example, on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Provider
  • Inviso Ltd
Size
  • 923.6 KB
Category
  • Health & Fitness
Compatibility
Requires iOS 15.0 or later.
  • iPhone
    Requires iOS 15.0 or later.
  • iPad
    Requires iPadOS 15.0 or later.
  • iPod touch
    Requires iOS 15.0 or later.
  • Mac
    Requires macOS 12.0 or later and a Mac with Apple M1 chip or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
  • English
Age Rating
18+
  • 18+
  • Infrequent
    Medical Treatment Information
Copyright
  • © 2023 Inviso Ltd.